NCT04255693 is a NA clinical trial of diet adherence in Gastroesophageal Reflux Disease, sponsored by Federal State Budgetary Scientific Institution "Federal Research Centre of Nutrition, Biotechnology.

What drugs are being tested in NCT04255693?

Interventions in NCT04255693: diet adherence, No diet adherence, Change in physical activity, No change in physical activity, Use of antisecretory agents, No use of antisecretory agents.

What condition does NCT04255693 study?

NCT04255693 studies Gastroesophageal Reflux Disease, GERD, Gastroesophageal Erosion, Erosive Esophagitis, Non-erosive Reflux Disease, Non-Erosive Gastro-Esophageal Reflux Disease.

Is NCT04255693 still recruiting?

NCT04255693 is currently recruiting now. Last updated 3 August 2025.

Last reviewed 2025-08-03 · How we verify

NCT04255693

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Real-life Study of Changes of Gastroesophageal Reflux Disease Manifestations Due to Behavioural and Diet Adherence

Recruiting now NA Last updated 3 August 2025

What this trial tests

NA trial testing diet adherence in Gastroesophageal Reflux Disease in 150 participants. Currently enrolling.

Timeline

31 January 2020

Primary endpoint
31 December 2027

31 December 2027

Quick facts

Lead sponsor	Federal State Budgetary Scientific Institution "Federal Research Centre of Nutrition, Biotechnology
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	non randomized
Design	parallel
Masking	single
Primary purpose	other
Enrollment	150
Start date	31 January 2020
Primary completion	31 December 2027
Estimated completion	31 December 2027
Sites	1 location across Russia

Drugs / interventions tested

diet adherence
No diet adherence
Change in physical activity
No change in physical activity
Use of antisecretory agents
No use of antisecretory agents

Conditions studied

Gastroesophageal Reflux Disease — all drugs for Gastroesophageal Reflux Disease →
GERD — all drugs for GERD →
Gastroesophageal Erosion — all drugs for Gastroesophageal Erosion →
Erosive Esophagitis — all drugs for Erosive Esophagitis →

Sponsor

Federal State Budgetary Scientific Institution "Federal Research Centre of Nutrition, Biotechnology

Who can join

Adults 18 to 80, any sex, with Gastroesophageal Reflux Disease or GERD. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study is aimed to investigate the role of long-term diet adherence on manifestations of gastroesophageal reflux disease

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Systematic mapping of registered interventional studies addressing the top 10 research priorities in Barrett's oesophagus and gastro-oesophageal reflux disease.
Gamakaranage C, Ratcliffe E, Britton J, Butler T, et al · · 2025 · PMID 40527525 · DOI 10.1136/bmjgast-2025-001738

Verify or expand the search:

Other recruiting trials for Gastroesophageal Reflux Disease

Currently open trials in the same condition.

NCT06783751 — Mechanistic and Clinical Outcomes of a Surgical Innovation Aimed at Minimizing GERD Associated With VSG (INNOVATE-VSG) · NA · recruiting
NCT06348420 — Anti-reflux Mucosal Valvuloplasty Versus PPIs for GERD Treatment · NA · recruiting
NCT06991348 — Clinical Trial for the Comparative Evaluation of Acid Suppression and Symptom Management of Gastroesophageal Reflux Dise · Phase 4 · recruiting
NCT06732661 — Preserving the Pre-cardial Fat Pad During Sleeve Gastrectomy on Postoperative Gastroesophageal Reflux · NA · active not recruiting
NCT05514769 — Proximal Gastrectomy Anterior Anastomosis With Pyloroplasty Versus Esophagogastric Anastomosis for Gastric Cancer · NA · recruiting

Other Federal State Budgetary Scientific Institution "Federal Research Centre of Nutrition, Biotechnology trials

Trials by the same sponsor.

NCT06727279 — Assessment of Tolerability of Specialized Food Products Made Out of Vegetable Protein and Their Influence on Lipid Profi · NA · not yet recruiting
NCT07121803 — The Influence of Specialized Food Products Based on Ice-Cream on Esophageal Motility · NA · recruiting
NCT06724913 — Efficacy and Tolerability of a Specialized Food Products for Dietary Therapeutic and Preventive Nutrition Based on Ice C · NA · active not recruiting
NCT05543811 — The Influence of Food for Special Dietary Use - Spread Enriched With 5-hydroxytryptophan, Theanine and Gamma-aminobutyri · NA · completed
NCT05224037 — Comparative Efficacy of Liver Fibrosis and Steatosis Assessment With Fibroscan and iLivTouch · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04255693 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Federal State Budgetary Scientific Institution "Federal Research Centre of Nutrition, Biotechnology
Last refreshed: 3 August 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04255693.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing